Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

360
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
360
Analgesia and Pain Management01:25

Analgesia and Pain Management

694
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
694
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

311
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
311
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

425
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
425
Bioequivalence: Overview01:16

Bioequivalence: Overview

1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Palliative Care Social Work Interventions and Co-occurring Outcomes: A Six-Year Descriptive Cohort.

Journal of pain and symptom management·2026
Same author

Retrospective Chart Review Evaluating Efficacy and Tolerability of Ketamine Continuous Infusion for Cancer-Related Pain.

The American journal of hospice & palliative care·2026
Same author

Mapping opioid exposure through prescription data and postmortem analysis of opioid drugs in multiple tissues.

British journal of clinical pharmacology·2026
Same author

Assessment of Curricular Integration of Compassionate Communication in Pharmacy Training.

American journal of pharmaceutical education·2026
Same author

In-Patient Medication Order Trends of Methadone and Buprenorphine for Chronic Pain and Opioid Use Disorder: A Multi-Center 10-Year Analysis Between 2014 and 2023.

Journal of pain & palliative care pharmacotherapy·2025
Same author

<i>Letter:</i> Optimizing Naloxegol Prescribing for Opioid-Induced Constipation.

Journal of palliative medicine·2025

Related Experiment Video

Updated: Aug 4, 2025

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.8K

Comparing National Methadone Equianalgesic Tools.

Raymond Y Wen, Kyle P Edmonds, Rabia S Atayee

    Journal of Pain & Palliative Care Pharmacotherapy
    |April 3, 2023
    PubMed
    Summary
    This summary is machine-generated.

    There is no consensus on methadone equianalgesia conversion tools. This study found significant variability among 18 institutional tools, preventing a recommended national consensus for methadone conversion.

    Keywords:
    Methadoneequianalgesicmethadone equianalgesiaopioid conversion

    More Related Videos

    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
    07:23

    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

    Published on: July 29, 2014

    33.4K
    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    9.7K

    Related Experiment Videos

    Last Updated: Aug 4, 2025

    Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
    09:38

    Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

    Published on: April 14, 2016

    12.8K
    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
    07:23

    Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

    Published on: July 29, 2014

    33.4K
    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    9.7K

    Area of Science:

    • Pharmacology
    • Pain Management
    • Palliative Care

    Background:

    • Methadone is an effective analgesic with complex pharmacokinetic and pharmacodynamic properties.
    • Establishing consistent equianalgesia conversion methods is crucial for safe and effective pain management.
    • Currently, no national consensus exists for methadone equianalgesia tools.

    Purpose of the Study:

    • To compare methadone equianalgesic tools from various national institutions.
    • To summarize current practices in methadone conversion.
    • To determine if a national consensus for methadone equianalgesia can be established.

    Main Methods:

    • Review of 25 institutional methadone equianalgesic tools.
    • Inclusion of 18 tools with sufficient data for analysis.
    • Evaluation of dose-dependent conversion modalities and common methods like the Hospice and Palliative Care (HAPC) Consensus.

    Main Results:

    • Significant variability was observed in the 18 evaluated methadone equianalgesia tools.
    • Fifteen tools employed diverse dose-dependent conversion methods.
    • The HAPC Consensus method was the most frequently utilized approach.

    Conclusions:

    • The wide variability in methadone equianalgesia tools precludes recommending a consensus conversion method.
    • Further research is necessary to explore and establish reliable methadone equianalgesia guidelines.
    • Current practices demonstrate a lack of standardization in methadone conversion strategies.